Cargando…

NK and NKT Cell-Mediated Immune Surveillance against Hematological Malignancies

Recent cancer treatment modalities have been intensively focused on immunotherapy. The success of chimeric antigen receptor T cell therapy for treatment of refractory B cell acute lymphoblastic leukemia has pushed forward research on hematological malignancies. Among the effector types of innate lym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimizu, Kanako, Iyoda, Tomonori, Yamasaki, Satoru, Kadowaki, Norimitsu, Tojo, Arinobu, Fujii, Shin-ichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226455/ https://www.ncbi.nlm.nih.gov/pubmed/32231116 http://dx.doi.org/10.3390/cancers12040817

Ejemplares similares

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses
por: Fujii, Shin-ichiro, et al.
Publicado: (2018)

Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells
por: Shimizu, Kanako, et al.
Publicado: (2015)

Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivity
por: Fujii, Shin-ichiro, et al.
Publicado: (2022)

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)

Augmenting Granzyme B–Expressing NK Cells by Invariant NKT Ligand–Loaded APCs in Patients with Postoperative Early Stage Non–Small Cell Lung Cancer: Results of a Randomized Phase II Study
por: Iyoda, Tomonori, et al.
Publicado: (2023)

Optimal therapeutic strategy using antigen‐containing liposomes selectively delivered to antigen‐presenting cells
por: Iyoda, Tomonori, et al.
Publicado: (2019)

Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic Cells
por: Fujii, Shin-ichiro, et al.
Publicado: (2017)

Zeb2 regulates differentiation of long-lived effector of invariant natural killer T cells
por: Iyoda, Tomonori, et al.
Publicado: (2023)

NKT Cells as an Ideal Anti-Tumor Immunotherapeutic
por: Fujii, Shin-ichiro, et al.
Publicado: (2013)

Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
por: Smyth, Mark J., et al.
Publicado: (2000)

Role of Circulating Tumor DNA in Hematological Malignancy
por: Ogawa, Miho, et al.
Publicado: (2021)

Detection of mutant antigen-specific T cell receptors against multiple myeloma for T cell engineering
por: Okada, Masahiro, et al.
Publicado: (2023)

Eomes transcription factor is required for the development and differentiation of invariant NKT cells
por: Shimizu, Kanako, et al.
Publicado: (2019)

In vivo dendritic cell targeting cellular vaccine induces CD4(+) Tfh cell-dependent antibody against influenza virus
por: Yamasaki, Satoru, et al.
Publicado: (2016)

Nonclonal chromosomal alterations and poor survival in cytopenic patients without hematological malignancies
por: Imataki, Osamu, et al.
Publicado: (2019)

NKT cell adjuvants in therapeutic vaccines against hematological cancers
por: Mattarollo, Stephen R., et al.
Publicado: (2013)

NK Cells in the Treatment of Hematological Malignancies
por: Gonzalez-Rodriguez, Ana P, et al.
Publicado: (2019)

Cytomegalovirus pulls strings behind NK cells
por: Kadowaki, Norimitsu, et al.
Publicado: (2017)

Hematological Malignancies Escape from NK Cell Innate Immune Surveillance: Mechanisms and Therapeutic Implications
por: Farnault, Laure, et al.
Publicado: (2012)

NK Cell-Based Immunotherapy for Hematological Malignancies
por: Sivori, Simona, et al.
Publicado: (2019)

A NK Cell Odyssey: From Bench to Therapeutics Against Hematological Malignancies
por: Ramos-Mejia, Veronica, et al.
Publicado: (2022)

PD-L1 Expression Affects Neoantigen Presentation
por: Okada, Masahiro, et al.
Publicado: (2020)

Impaired NK and NKT cells immunobiology in rheumatoid arthritis
por: Aggarwal, Ashish, et al.
Publicado: (2012)

NK and NKT-Like Cells in Patients with Recurrent Furunculosis
por: Nowicka, Danuta, et al.
Publicado: (2017)

Cancer immunotherapy using artificial adjuvant vector cells to deliver NY‐ESO‐1 antigen to dendritic cells in situ
por: Fujii, Shin‐ichiro, et al.
Publicado: (2022)

Monitoring NK cell activity in patients with hematological malignancies
por: Viel, Sébastien, et al.
Publicado: (2013)

Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8(+) T cells against tumor
por: Shimizu, Kanako, et al.
Publicado: (2023)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
por: McNerney, Kevin O., et al.
Publicado: (2020)

CAR-NK cell therapeutics for hematologic malignancies: hope is on the horizon
por: Xu, Kai-lin, et al.
Publicado: (2019)

miR-150 regulates the development of NK and iNKT cells
por: Bezman, Natalie A., et al.
Publicado: (2011)

Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking
por: Eriksson Ström, Jonas, et al.
Publicado: (2018)

Abstract 2 Development of CAR-NK Cell Therapy for Hematologic Malignancies
por: Stoltzman, Carrie, et al.
Publicado: (2022)

α‐Galactosylceramide‐activated murine NK1.1(+) invariant‐NKT cells in the myometrium induce miscarriages in mice
por: Ichikawa, Tomoko, et al.
Publicado: (2016)

Programmed cell death 1‐expressing CD56‐negative natural killer (NK) cell expansion is a hallmark of chronic NK cell activation during dasatinib treatment
por: Ishiyama, Ken‐ichi, et al.
Publicado: (2020)

Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2
por: Shimizu, Kanako, et al.
Publicado: (2021)

Augmentation of NKT and NK cell-mediated cytotoxicity by peptidoglycan monomer linked with zinc.
por: Mrakovcić-Sutić, Ines, et al.
Publicado: (2002)

Anaplasma phagocytophilum-Related Defects in CD8, NKT, and NK Lymphocyte Cytotoxicity
por: Scorpio, Diana G., et al.
Publicado: (2018)

Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT
por: Tumino, Nicola, et al.
Publicado: (2021)

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer
por: Smyth, Mark J., et al.
Publicado: (2005)

NK and NKT cells in the diagnosis of diffuse lung diseases presenting with a lymphocytic alveolitis
por: Sokhatska, Oksana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m4fd1otipld65t7bo9lo6bghvc